Newmanbrain, finalist in the IV Innova eVIA Awards for its technology for biomedical use

The spin-off of the UMH Science Park, Newmanbrain, has been chosen as a finalist in the Innova Project category of the IV Innova eVIA Awards Contest. The company has specialized in the development of software and hardware for biomedical use, mainly in the areas of neuroscience and biomedicine. After the first selection of finalists, a jury of experts will carry out a second evaluation in which the three winners of each category will be selected. The Innova eVIA Awards seek to recognize the effort and scientific and innovative excellence of solutions and services developed in the field of technologies applied to Health and Active and Independent Living.

As the CEO of the spin-off, Pablo Belmonte, points out, this recognition represents an important boost for the company: “Being among the best in the area of ​​technology applied to neurosciences and having them recognize the effort made is a great satisfaction for our team.” In addition, as part of his award, Newmanbrain will be able to publicize his project in the exhibition that this contest has organized. This will take place during the awards ceremony to be held on Thursday, March 22 in Madrid.

During this event, the spin-off of the UMH Science Park will present to attendees some of the innovative technologies that they have developed for biomedical use. “We will showcase how our device, a portable system that uses near-infrared (fNIR) technology to measure and record brain functions, works.” says Belmonte. In addition, the company will show how this device helps to relate the response to certain stimuli (affective, cognitive, etc.) and the changes in cerebral blood flow that occur during mental activity.

Newmanbrain is promoted by the former director of the Institute of Neurosciences (IN), a hybrid institute between the UMH and the Higher Council for Scientific Research (CSIC), and professor emeritus of the UMH, Carlos Belmonte, by the worker of the Institute of Neurosciences Alejandro Méndez, by the director of the Department of Physiology of the UMH, Joaquín Ibáñez, and by Pablo Belmonte. Currently, the company is focused on improving the software and hardware of its device to make it a product in high demand for psychology professionals and other potential buyers. Likewise, the company is developing new equipment for the assessment of various biological functions, using fNIR technology.

Source: Parque Científico de la UMH